Article info

SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
Free

Authors

  1. Correspondence to Professor Daniel Aletaha, Department of Medicine III, Division of Rheumatology, Medical University of Vienna, 1090 Vienna, Austria; daniel.aletaha{at}meduniwien.ac.at
View Full Text

Citation

Mrak D, Tobudic S, Koblischke M, et al
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity

Publication history

  • Received May 13, 2021
  • Accepted July 12, 2021
  • First published July 20, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.